A poly(ADP-ribose) polymerase inhibitor, benzamide (BA), was found to induce flat revertants of NIH 3T3 cells that had been transformed by human Ha-ras, rat Ki-ras, rat c-raf, and human ret-Il. These genes had been amplified in original transformants, but they were completely eliminated by BA. Contrary to this, endogenous activated Ha-ras in a human bladder carcinoma cell line, T24, was not eliminated by BA. The gene loss seemed to be restricted to exogenous and/or amplified sequences. BA also eliminated the amplified c-myc gene in HL-60 cells, concomitant with differentiation into granulocytes. We demonstrated that the amplified c-myc gene was not present as episomes. It is probably present as double minutes or a homogeneously staining region. Dimethylsulfoxide also induced differentiation at a concentration that did not inhibit poly(ADP-ribose) polymerase. The cell lost the c-myc gene in association with this differentiation. The amplified c-myc gene in a colon adenocarcinoma cell line, COLO 320HSR, and the amplified mdr-1 gene in an adriamycin-resistant myelogenous leukemia cell line, K562/ADM, were not eliminated by BA. Various poly(ADP-ribose) polymerase inhibitors also eliminated human Ha-ras in the NIH 3T3 transformant and the c-myc gene in HL-60 cells.
Introduction
Carcinogenesis is a multistep process involving mutation, amplification, loss, and rearrangement of genes. Oncogene amplification is often associated with malignant progression. For instance, amplification of the cmyc gene is often observed in advanced cases of uterus cervical cancer (1) and advanced cases of breast cancer (2) , while amplification of N-myc is often observed in advanced cases of neuroblastoma (3) . Recently, we found that poly(ADP-ribose) polymerase inhibitors eliminated the exogenous amplified sequence in NIH 3T3 transformants (4) .
Poly(ADP-ribose) polymerase [ADP-ribosyltransferase(polymerizing); EC 2.4.2.30] modifies a number of proteins by transferring the ADP-ribose moiety of nicotinamide adenine dinucleotide (NAD) to the protein and polymerizing it (5, 6) . Inhibitors of poly(ADP-ribose) polymerase such as benzamide (BA) and 3-aminobenzamide are potent inducers of sister chromatid exchanges (7) . These inhibitors also inhibit DNA replication, causing concomitant accumulation of nascent 10 kb DNA (8) , inhibition of DNA repair (9) , and modulation of cell differentiation (10) (11) (12) . 3-Aminobenzamide has been shown to enhance alkylating agent-in-duced amplification of SV-40 DNA integrated into cellular DNA of the host (13) . Recently, a mutant of Chinese hamster V79 cells with very low poly(ADPribose) polymerase activity was isolated and shown to be a slow grower, to be sensitive to alkylating agents, and to have a much higher background level of sister chromatid exchanges than the parental V79 cells (14) . These findings show that poly(ADP-ribose) polymerase is involved in DNA repair and suppression of sister chromatid exchanges.
In this study, we examined the effects of poly(ADPribose) polymerase inhibitors on amplified genes using several NIH 3T3 transformants harboring different oncogenes: a human promyelocytic leukemic cell line, HL-60, in which endogenous c-myc is amplified, a human colon carcinoma cell line, COLO 320HSR, in which cmyc is amplified as a homogeneously staining region (HSR), and a human myelogenous leukemic cell line, K562/ADM, in which the mdr-1 gene is amplified. Southern blot analysis using the v-Ha-ras DNA fragment (BS-9) as a probe, the intensity of hybridization of the human c-Ha-ras sequence in al-1 cells was four times that of the endogenous mouse c-Ha-ras sequence. Its hybridization intensity did not change during culture for 4 weeks in the absence of benzamide. Addition of 5 mM benzamide to the medium did not change the hybridization intensity of endogenous mouse c-Ha-ras, but specifically reduced that of the exogenous ras sequence (Fig. 1) . These results indicated that flat reversion of al-1 cells was due to loss of the exogenous transforming gene. There are two possible explanations for the effect of BA; one is that BA might cause selection of flat cells that were induced spontaneously, and the other is that BA might cause specific elimination of the exogenous transforming gene. To clarify the action of BA, we examined its effect on al-1 cells without cell transfer.
Results

Elimination of Exogenous
al-1 Cells were plated at a density of 30 cells/10 cm diameter Petri dish, BA was added on day 2, and the cultures were maintained for 2 weeks. The cell morphology of the colonies was then examined. Each colony was found to contain many clusters of flat revertants surrounded by transformed cells (Fig. 2) , indicating the induction, but not the selection, of flat cells.
By cloning these cells, five clones each of transformed cells and flat cells were obtained. Southern blotting showed that all five clones of flat cells had lost the activated human c-Ha-ras sequence, whereas all five clones of transformed cells still retained whole copies of activated human c-Ha-ras. No change of the endogenous mouse c-Ha-ras gene was observed in these 10 clones. We also found that BA had no effect on the human c-Ha-rasT24 sequence in T24 cells, in which it exists as a nonamplified homozygous sequence. There- fore, we conclude that BA caused elimination of exogenous and/or amplified sequences. Poly(ADP-ribose) polymerase is composed of three domains, NAD binding, automodification, and DNAbinding domains (6) and has two contiguous zinc-finger structures (15) . Not only BA, a competitor with substrate NAD, but also the DNA site inhibitor, coumarin (4), and a newly found potent inhibitor, luminol (4), induced flat revertants efficiently (Table 1) . On the contrary, noninhibitory analogues of BA, benzoic acid and 3-aminobenzoic acid did not induce flat revertants of al-1 cells. Thus, elimination of exogenous amplified sequences seems to be an intrinsic property of poly(ADPribose) polymerase inhibitors.
Other transfected genes such as activated Ki-ras, Nras, c-raf, and ret-II were also very efficiently eliminated by culturing the transformants in the presence of 5 mM BA for 2 weeks (4), and these BA-treated cells were also flattened. These activated oncogenes were of rat (Ki-ras) or human (N-ras, c-raf and ret-II) origin; that is, they were derived from a different species from the host cells. and lysed with sodium N-lauroylsarcosinate, and the uncut DNA was separated by PFGE as described (21 Under these conditions, cell growth was reduced to about 50% of that in control cultures. In the presence of 5 mM BA, more than 50% of the cells became tightly adherent to the substrate, whereas only a few cells were loosely adherent in the absence of BA (Fig. 4) . These adherent cells in cultures with benzamide were flat, clearly differing in morphology from cells in control cultures. Nonadherent cells in cultures with 5 mM BA were removed by pipette with vigorous shaking to separate them from adherent cells, and the DNAs of these nonadherent and adherent cells and also of untreated cells were extracted. Southern blot analysis indicated that the hybridization intensity of c-myc was not changed in these flat cells. Thus, the change of cell morphology induced by BA was not associated with loss of the amplified c-myc gene.
When the cells were cultured in uncoated flasks, they grew in suspension. Additions of high concentrations of polymerase inhibitors, 5 mM 4-hydroxyquinazoline or 12.5 mM BA, inhibited cell growth almost completely, but no loss of the c-myc gene was found after 20 days of treatment with either of these inhibitors. These results indicate that the amplified endogenous c-myc gene is not necessarily eliminated by poly(ADP-ribose) polymerase inhibitors.
Effect of BA on the Amplified mdr-1 Gene in K562/ADM Cells Serious problems in cancer therapy are resistance of progressed cancer cells to chemotherapeutic agents and the acquisition of resistance during treatment. We examined the effect of poly(ADP-ribose) polymerase inhibitors on the amplified mdr-1 gene induced by adriamycin treatment in myelogenous leukemia K562 cells, K562/ADM (provided by T. Tsuruo, University of Tokyo) (22) . We isolated three clones of K562/ADM, K562/ ADM-1, K562/ADM-2, and K562/ADM-3, and two clones of K562, K562-1 and K562-2. Southern blot analysis of digest of these DNAs with HindIII, using pMDR1 (provided by I. B. Roninson, University of Illinois) as a probe indicated that K562/ADM-1-3 have an amplified mdr-1 gene, as shown in Figure 5 . When these cells were treated with various concentrations of BA, their growth rates were reduced dose dependently, about 50% growth inhibition being observed with 5 mM BA. This dose-dependent inhibition of cell growth by BA suggests that BA was taken up into these cells in spite of the presence of the amplified mdr-1 gene. Figure 5 shows that there was no loss of the mdr-1 gene even after culture for 5 weeks in the presence of 5 mM BA.
Discussion
Poly(ADP-ribose) polymerase inhibitors were found to eliminate exogenous and amplified sequences efficiently. In To characterize the gene eliminating activity of poly(ADP-ribose) polymerase inhibitors, we focused attention on amplified sequences. We chose HL-60 cells, a hematopoietic cell line with amplified c-myc that is known to differentiate into granulocytes on treatment with poly(ADP-ribose) polymerase inhibitors. We also examined the effect of polymerase inhibitors on COLO 320HSR, which is an epithelial cell line in which the status of amplified c-myc has been determined (21) . Thirdly, we used K562/ADM, a hematopoietic cell line in which a nononcogenic gene, mdr-1, is known to be amplified, but the effect of polymerase inhibitors on cell differentiation was unknown.
In the HL-60 cells used in this study, the c-myc gene was found not to be present as episomes, but probably as DMs or HSR (on chromosome 8). The c-myc gene was eliminated by treatment with poly(ADP-ribose) polymerase inhibitors. It is unknown, however, whether polymerase inhibitors eliminated all the c-myc genes in differentiated cells or only reduced their copy number per cell. HL-60 cells differentiated into granulocytes and did not grow any more after granulocytic differentiation. Therefore, in situ hybridization will be necessary to determine whether the differentiated cells contain any copies of the c-myc gene. Gene loss was also observed on treatment with DMSO. The mechanism of induction of differentiation of HL-60 cells by DMSO has not been fully elucidated. As described in the text, DMSO at a concentration of 1.6% probably does not inhibit poly(ADP-ribose) polymerase. We are now measuring the amounts of poly(ADP-ribose) in HL-60 cells treated with BA or DMSO using an antibody against poly(ADP-ribose) to determine whether these compounds inhibit the poly(ADP-ribosyl)ation reaction in vivo. We are also examining whether other types of granulocytic inducers also cause loss of the c-myc gene.
We also used another cell line, COLO 320HSR, in which the amplified c-myc gene has been shown to be present as HSR on chromosome X. BA induced morphological changes of these cells but not c-myc gene loss. From these findings, two possibilities can be considered. One is that the c-myc gene in the HL-60 cells used in this study is present as DMs, and the sequence on DMs can be eliminated by poly(ADP-ribose) polymerase inhibitors. The other is that loss of the amplified endogenous c-myc is associated with granulocytic cell differentiation, which is associated with segmentation of the nuclei.
Another amplified endogenous gene, mdr-1, in K562/ ADM, was not eliminated by poly(ADP-ribose) polymerase inhibitors. From these results we conclude that certain conditions are necessary for elimination of amplified endogenous genes by poly(ADP-ribose) polymerase inhibitors. We are now examining the effect of poly(ADP-ribose) polymerase inhibitors on integrated viral sequences to determine whether these exogenous sequences can be eliminated by poly(ADP-ribose) polymerase inhibitors.
